His main research concerns Genetics, Cancer research, Gene, Cancer and Exome. His Cancer research study combines topics from a wide range of disciplines, such as DNA methylation, Bioinformatics, Transcriptome, CDKN2A and PTEN. His work carried out in the field of DNA methylation brings together such families of science as 1p/19q Codeletion, Serous fluid, Microsatellite instability, KRAS and microRNA.
He has researched Gene in several fields, including Melanoma and Adenocarcinoma. Michael S. Lawrence has included themes like Exome sequencing, Fusion gene, Immunology and Chronic lymphocytic leukemia in his Cancer study. His Exome study incorporates themes from Glioma, Pathology, Breast cancer, Mutation rate and Genetic heterogeneity.
Michael S. Lawrence spends much of his time researching Genetics, Cancer research, Gene, Cancer and Mutation. His studies in Genome, Exome, Exome sequencing, Germline mutation and Somatic cell are all subfields of Genetics research. His biological study spans a wide range of topics, including Genetic heterogeneity and Adenocarcinoma.
His Cancer research study also includes fields such as
The scientist’s investigation covers issues in Cancer research, Computational biology, Gene, Cancer and Genome. The Cancer research study combines topics in areas such as Cell, DNA damage, Cancer cell, Carcinogenesis and Lung cancer. His studies in Computational biology integrate themes in fields like Mutagenesis, DNA methylation, APOBEC3A, Cluster analysis and Genomics.
Gene connects with themes related to Oxidative phosphorylation in his study. His Genome study improves the overall literature in Genetics. Michael S. Lawrence connects Genetics with Gene nomenclature in his research.
The scientist’s investigation covers issues in Computational biology, Cancer research, Genome, Gene and Lung cancer. His Computational biology research is multidisciplinary, relying on both International Prognostic Index, DNA methylation, Mutation, Genomics and DNA replication. His Cancer research study combines topics in areas such as Cancer, Oncogene, microRNA and Transcription factor.
His Genome research integrates issues from Chromothripsis, Germline mutation, Aneuploidy and Point mutation. Aneuploidy is a subfield of Genetics that Michael S. Lawrence explores. Carcinogenesis and Missense mutation are among the areas of Gene where the researcher is concentrating his efforts.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak;Katherine A. Hoadley;Elizabeth Purdom;Victoria Wang.
Cancer Cell (2010)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
The cancer genome atlas pan-cancer analysis project
John N Weinstein;John N Weinstein;Eric A. Collisson;Gordon B Mills;Kenna R Mills Shaw;Kenna R Mills Shaw.
Nature Genetics (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny;Matthew N. Bainbridge;Kyle Chang;Huyen H. Dinh.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds.
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence;Petar Stojanov;Petar Stojanov;Paz Polak;Paz Polak;Paz Polak;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis;Michael S Lawrence;Scott L Carter;Andrey Sivachenko.
Nature Biotechnology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: